Drug profile · INN
patiromer sorbitex calcium
VELTASSA
patiromer sorbitex calcium (VELTASSA) is a potassium chelating agent. Route of administration: oral. Current US regulatory status: approved.
Drug details — patiromer sorbitex calcium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
patiromer sorbitex calcium (VELTASSA) is a potassium chelating agent. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Potassium chelating agent
Primary target: Potassium
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is patiromer sorbitex calcium?
patiromer sorbitex calcium (VELTASSA) is a potassium chelating agent. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for patiromer sorbitex calcium?
VELTASSA is a marketed brand name for patiromer sorbitex calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of patiromer sorbitex calcium?
patiromer sorbitex calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.